Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccination for melanoma.

L W Thompson1, L Brinckerhoff, C L Slingluff

  • 1Department of Surgery, University of Virginia Health Science Center, PO Box 10005, Charlottesville, VA 22906-0005, USA.

Current Oncology Reports
|December 21, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Statistical controversies in clinical research: early-phase adaptive design for combination immunotherapies.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Recent developments in the implementation of novel designs for early-phase combination studies.

Annals of oncology : official journal of the European Society for Medical Oncology·2015
Same author

Visual event-related potentials and depression in the elderly.

Neurobiology of aging·2013
Same author

An ossifying fibroma of the coronoid process.

Plastic and reconstructive surgery·2010
Same author

Well-being, appraisal, and coping in Latina and Caucasian female dementia caregivers: findings from the REACH study.

Aging & mental health·2004
Same author

gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells.

British journal of cancer·2001
Same journal

Revisiting the Immunological Landscape of Locoregional Therapies for Gastrointestinal Cancers: A Shift Toward Interventional Immuno-Oncology.

Current oncology reports·2026
Same journal

Anti-PD-1 Combinations: Triplets and Beyond.

Current oncology reports·2026
Same journal

Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple Diseases.

Current oncology reports·2026
Same journal

Clusterin in Head and Neck Squamous Cell Carcinoma: Diagnostic, Prognostic, and Therapeutic Implications.

Current oncology reports·2026
Same journal

Cardiac Risk Without a Roadmap: Lack of Evidence-Based Guidance for Cardiovascular Toxicity of T-Cell Redirecting Therapies.

Current oncology reports·2026
Same journal

Current Understanding of CHIP's Immunobiological Footprint with A Focus on Gastrointestinal Disorders: A Review of the Literature.

Current oncology reports·2026
See all related articles

Cancer vaccines have evolved significantly over 50 years. Current melanoma vaccination strategies show promise for treating metastatic melanoma, offering new hope for patients.

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • Significant advancements in understanding the immune system over the past 50 years.
  • Melanoma is recognized as a highly immunogenic solid tumor.
  • While early-stage melanoma is treatable with surgery, advanced stages remain a significant cause of mortality.

Purpose of the Study:

  • To review the current landscape of melanoma vaccination.
  • To discuss the development and clinical status of cancer vaccines for melanoma.

Main Methods:

  • Review of clinical and laboratory evidence regarding melanoma immunogenicity.
  • Analysis of the current status of ongoing clinical trials for melanoma vaccines.
  • Synthesis of data on the effectiveness of vaccines for metastatic melanoma.

Related Experiment Videos

Main Results:

  • Melanoma exhibits higher immunogenicity compared to other solid tumors.
  • Numerous clinical trials investigating melanoma vaccines are currently active.
  • Vaccines targeting metastatic melanoma have demonstrated preliminary clinical efficacy.

Conclusions:

  • Melanoma vaccination represents a developing and promising therapeutic strategy.
  • Continued research and clinical trials are essential for advancing melanoma treatment.
  • Understanding the immune system's role is key to successful cancer vaccine development.